press-banner
press
Released date: February 18, 2017

AI for Selection of Combination Therapies

press
Released date: September 15, 2016

Oh! It’ll be you then…Hotspot Goes Biosimilar!

press
Released date: July 7, 2016

From Doomed to Deemed: Brodalumab Continues Its Long Fateful Journey

Leo Pharma, an established company in psoriasis treatment, took analysts by surprise when it obtained the development and commercialization rights in Europe for brodalumab, an IL-17R antagonist. Valeant Pharmaceuticals had previously acquired broad worldwide rights to brodalumab from AstraZeneca in Read More